PHENERGAN- promethazine hydrochloride injection United States - English - NLM (National Library of Medicine)

phenergan- promethazine hydrochloride injection

remedyrepack inc. - promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - phenergan injection is indicated for the following conditions: - amelioration of allergic reactions to blood or plasma. - in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled. - for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. - for sedation and relief of apprehension and to produce light sleep from which the patient can be easily aroused. - active treatment of motion sickness. - prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery. - as an adjunct to analgesics for the control of postoperative pain. - preoperative, postoperative, and obstetric (during labor) sedation. - intravenously in special surgical situations, such as repeated bronchoscopy, ophthalmic surgery, and poor-risk patients, with reduced amounts of meperidine or other narcotic analgesic as an adjunct to anesthesia and analgesia. phenergan injection is contraindicated for use in pediatric patients less than two years of age due to the risk of respiratory depression ( see  warnings - respiratory depression) . phenergan injection is contraindicated in comatose states. under no circumstances should phenergan injection be given by intra-arterial injection due to the likelihood of severe arteriospasm and the possibility of resultant gangrene (see warnings - severe tissue injury, including gangrene). phenergan injection should not be given by the subcutaneous route because evidence of chemical irritation has been noted, and necrotic lesions have resulted following subcutaneous injection. the preferred parenteral route of administration is by deep intramuscular injection. phenergan injection is contraindicated in patients who have demonstrated an idiosyncratic reaction or hypersensitivity to promethazine or other phenothiazines.

PHENERGAN promethazine hydrochloride 25mg tablet  blister pack (reformulation) Australia - English - Department of Health (Therapeutic Goods Administration)

phenergan promethazine hydrochloride 25mg tablet blister pack (reformulation)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - promethazine hydrochloride, quantity: 25 mg - tablet, film coated - excipient ingredients: lactose monohydrate; hypromellose; magnesium stearate; maize starch; povidone; macrogol 200; titanium dioxide; indigo carmine; purified water; industrial methylated spirit - allergies: treatment of allergic conditions including some allergic reactions to drugs, urticaria, contact dermatitis, and allergic reactions to insect bites and stings. upper respiratory tract: relief of excesive secretion in the upper respiratory tract as a result of hayfever and allergic rhinitis. nausea and vomiting: antiemetic in vomiting of various causes, including post-operative vomiting, irradiation sickness, drug induced nausea, and motion sickness. sedation: for short term use on the advice of a doctor or pharmacist.

PHENERGAN promethazine hydrochloride 10mg tablet  blister pack (reformulation) Australia - English - Department of Health (Therapeutic Goods Administration)

phenergan promethazine hydrochloride 10mg tablet blister pack (reformulation)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - promethazine hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; macrogol 200; maize starch; lactose monohydrate; hypromellose; titanium dioxide; indigo carmine; purified water; industrial methylated spirit - allergies: treatment of allergic conditions including some allergic reactions to drugs, urticaria, contact dermatitis, and allergic reactions to insect bites and stings. upper respiratory tract: relief of excesive secretion in the upper respiratory tract as a result of hayfever and allergic rhinitis. nausea and vomiting: antiemetic in vomiting of various causes, including post-operative vomiting, irradiation sickness, drug induced nausea, and motion sickness. sedation: for short term use on the advice of a doctor or pharmacist.

PHENERGAN ELIXIR promethazine hydrochloride 1mg/mL bottle (reformulation) Australia - English - Department of Health (Therapeutic Goods Administration)

phenergan elixir promethazine hydrochloride 1mg/ml bottle (reformulation)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - promethazine hydrochloride, quantity: 1 mg/ml - oral liquid - excipient ingredients: citric acid monohydrate; purified water; sodium benzoate; acesulfame potassium; caramel; ascorbic acid; sodium sulfite; maltitol solution; sodium citrate dihydrate; sodium metabisulfite; flavour - allergies: treatment of allergic conditions including some allergic reactions to drugs, urticaria, contact dermatitis and allergic reactions to insect bites and stings. upper respiratory tract: relief of excessive secretion in the upper respiratory tract as a result of hayfever and allergic rhinitis. nausea and vomiting: antiemetic in vomiting of various causes including post-operative vomiting, irradiation sickness, drug induced nausea and motion sickness. sedation: for short term use on the advice of a doctor or pharmacist.

Phenergan New Zealand - English - Medsafe (Medicines Safety Authority)

phenergan

pharmacy retailing (nz) ltd t/a healthcare logistics - promethazine hydrochloride 1 mg/ml - elixir - 0.1% w/v - active: promethazine hydrochloride 1 mg/ml excipient: acesulfame potassium ascorbic acid caramel citric acid monohydrate hydrogenated glucose syrup orange flavour juice 510844e purified water sodium benzoate sodium citrate dihydrate sodium metabisulfite sodium sulfite - 1. treatment of allergic conditions including some allergic reactions to drugs, urticaria and allergic contact dermatitis, and allergic reactions to insect bites and stings 2. relief of excessive secretion in the upper respiratory tract as a result of hayfever and allergic rhinitis 3. anti-emetic for vomiting from various causes including post-operative vomiting, irradiation sickness, drug induced nausea and motion sickness 4. sedation - for short term use in adults under the advice of a doctor or pharmacist, do not use for more than 7-10 consecutive days 5. promethazine can be used as a pre-anaesthetic medication for the prevention and control of post-operative vomiting.

Phenergan New Zealand - English - Medsafe (Medicines Safety Authority)

phenergan

pharmacy retailing (nz) ltd t/a healthcare logistics - promethazine hydrochloride 10mg - tablet - 10 mg - active: promethazine hydrochloride 10mg excipient: hypromellose lactose monohydrate macrogol 200 magnesium stearate maize starch opaspray blue m-1-4210a povidone - 1. treatment of allergic conditions including some allergic reactions to drugs, urticaria and allergic contact dermatitis, and allergic reactions to insect bites and stings 2. relief of excessive secretion in the upper respiratory tract as a result of hayfever and allergic rhinitis 3. anti-emetic for vomiting from various causes including post-operative vomiting, irradiation sickness, drug induced nausea and motion sickness 4. sedation - for short term use in adults under the advice of a doctor or pharmacist, do not use for more than 7-10 consecutive days 5. promethazine can be used as a pre-anaesthetic medication for the prevention and control of post-operative vomiting.

Phenergan New Zealand - English - Medsafe (Medicines Safety Authority)

phenergan

pharmacy retailing (nz) ltd t/a healthcare logistics - promethazine hydrochloride 25mg - tablet - 25 mg - active: promethazine hydrochloride 25mg excipient: hypromellose lactose monohydrate macrogol 200 magnesium stearate maize starch opaspray blue m-1-4210a povidone - 1. treatment of allergic conditions including some allergic reactions to drugs, urticaria and allergic contact dermatitis, and allergic reactions to insect bites and stings 2. relief of excessive secretion in the upper respiratory tract as a result of hayfever and allergic rhinitis 3. anti-emetic for vomiting from various causes including post-operative vomiting, irradiation sickness, drug induced nausea and motion sickness 4. sedation - for short term use in adults under the advice of a doctor or pharmacist, do not use for more than 7-10 consecutive days 5. promethazine can be used as a pre-anaesthetic medication for the prevention and control of post-operative vomiting.

PHENERGAN- promethazine hydrochloride injection United States - English - NLM (National Library of Medicine)

phenergan- promethazine hydrochloride injection

hikma pharmaceuticals usa inc. - promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - promethazine hydrochloride 25 mg in 1 ml - phenergan injection is indicated for the following conditions: - amelioration of allergic reactions to blood or plasma. - in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled. - for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. - for sedation and relief of apprehension and to produce light sleep from which the patient can be easily aroused. - active treatment of motion sickness. - prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery. - as an adjunct to analgesics for the control of postoperative pain. - preoperative, postoperative, and obstetric (during labor) sedation. - intravenously in special surgical situations, such as repeated bronchoscopy, ophthalmic surgery, and poor-risk patients, with reduced amounts of meperidine or other narcotic analgesic as an adjunct to anesthesia and analgesia. phenergan injection is contraindicat

PHENERGAN- promethazine hydrochloride injection United States - English - NLM (National Library of Medicine)

phenergan- promethazine hydrochloride injection

hikma pharmaceuticals usa inc. - promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - phenergan injection is indicated for the following conditions: - amelioration of allergic reactions to blood or plasma. - in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled. - for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. - for sedation and relief of apprehension and to produce light sleep from which the patient can be easily aroused. - active treatment of motion sickness. - prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery. - as an adjunct to analgesics for the control of postoperative pain. - preoperative, postoperative, and obstetric (during labor) sedation. - intravenously in special surgical situations, such as repeated bronchoscopy, ophthalmic surgery, and poor-risk patients, with reduced amounts of meperidine or other narcotic analgesic as an adjunct to anesthesia and analgesia. phenergan injection is contraindicat

Phenergan 25mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

phenergan 25mg tablets

sanofi consumer healthcare - promethazine hydrochloride - oral tablet - 25mg